Ortivus

1,22 SEK

0,00 %

Mindre end 1K følgere

ORTI B

First North Stockholm

Medical Equipment & Services

Health Care

Oversigt

Finansielt overblik og estimater

Ejerskab

Investorkonsensus

0,00 %

0,00 %

+7,02 %

-18,12 %

-12,23 %

-25,84 %

-77,07 %

-75,55 %

-98,97 %

Ortivus is engaged in the health care sector. The company specializes in the development of mobile solutions. The services include, for example, monitoring and communication solutions that are further used in decision-making and support systems. Today, the solutions are resold under various brands. The largest business operations are held in the Nordic region, and Europe. Ortivus was established in 1985 and is headquartered in Danderyd.

Markedsværdi

108,11 mio. SEK

Aktieomsætning

717,63 t SEK

Omsætning

80,41 mio.

EBIT %

-24,29 %

P/E

-

Udbytteafkast, %

-

Omsætning og EBIT-margin

Omsætning mio.

EBIT-% (adj.)

EPS og udbytte

EPS (adj.)

Udbytte %

Finanskalender

20.2

2026

Årsrapport '25

Alle

Selskabsmeddelelser

ViserAlle indholdstyper

Selskabsmeddelelse2.12.2025, 07.53

Ortivus announces mandatory public offer from Ponderus Invest AB

Selskabsmeddelelse28.11.2025, 07.30

Interim Report for Ortivus AB (publ) for the period July – September 2025

Selskabsmeddelelse14.11.2025, 14.30

ORTIVUS INFORMS ABOUT A POSSIBLE MANDATORY BID FROM PONDERUS INVEST

Bliv en del af Inderes community

Gå ikke glip af noget - opret en konto og få alle de mulige fordele

Inderes konto

Følgere og notifikationer om fulgte virksomheder

Analytikerkommentarer og anbefalinger

Værktøj til at sammenligne aktier og andre populære værktøjer

Selskabsmeddelelse15.10.2025, 06.35

Ortivus announces that CFO Johan Wewel has decided to leave his position

Selskabsmeddelelse9.10.2025, 14.00

All conditions for the Subscription Guarantee in Ortivus AB’s ongoing Rights Issue now fulfilled

Pressemeddelelse7.10.2025, 07.15

Ortivus presents its operations and future market opportunities

Selskabsmeddelelse30.9.2025, 07.45

Ortivus publishes information document regarding Rights Issue of shares

Pressemeddelelse25.9.2025, 06.30

First day of trading in Ortivus' shares without the right to obtain subscription rights regarding the share issue

Pressemeddelelse24.9.2025, 11.15

Last day for trading in Ortivus's shares including the right to participate in the share issue

Selskabsmeddelelse19.9.2025, 14.10

Press release from the Extraordinary General Meeting of Ortivus AB regarding Rights Issue

Selskabsmeddelelse9.9.2025, 06.30

Ortivus announces intended allocation of proceeds from the proposed rights issue following agreement with the main shareholder on a new credit facility

Selskabsmeddelelse26.8.2025, 08.15

Ortivus’ Main Shareholder Ponderus Invest AB Extends Credit Facility Agreement with Ortivus

Pressemeddelelse25.7.2025, 12.45

Ortivus Secures Two-Year Contract Extension with South Central Ambulance Service (SCAS)

Pressemeddelelse17.6.2025, 06.30

Ortivus secures two-year contract extension with South Western Ambulance Service (SWASFT)

Selskabsmeddelelse9.6.2025, 06.00

Ortivus reaches agreement on the termination of the project with the Estonian Health Insurance Fund

Pressemeddelelse26.5.2025, 13.45

Ortivus receives two-year contract extension from Northern Ireland Ambulance Service (NIAS)

Selskabsmeddelelse9.5.2025, 06.35

Correction: Interim Report for Ortivus AB (publ) for the period January - March 2025

Selskabsmeddelelse8.5.2025, 06.30

Interim Report for Ortivus AB (publ) for the period January - March 2025

Selskabsmeddelelse11.4.2025, 08.35

Correction: The Board of Directors of Ortivus AB withdraws the proposal to the Annual General Meeting on 8 May 2025 regarding authorisation for the Board to issue shares, etc.

Pressemeddelelse11.3.2025, 15.00

We are pleased to welcome two new colleagues to Ortivus!

Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.